Synbiotics Limited, only manufacturer of the API Amphotericin B

India is witnessing an outbreak of MUCORMYCOSIS - a very fast spreading fungal infection especially for post-COVID infection and recovery because of low immune system in the patients. The most recommended treatment for this infection is Amphotericin B injection.

We wish to inform you that Synbiotics Limited, a subsidiary of Ambalal Sarabhai Enterprises Limited (ASE), is the only manufacturer of the Active Pharmaceutical Ingredient (API) Amphotericin B in India and looking at the current outbreak of MUCORMYCOSIS and expected requirement, Synbiotics has ramped up the manufacturing capacity to meet the requirement of this most effective anti-fungal Antibiotic in the post Covid crisis.

Synbiotics Limited has the State of the Art fermentation plant for the manufacturing of the API Amphotericin B.

Shares of AMBALAL SARABHAI ENTERPRISES LTD. was last trading in BSE at Rs.27.85 as compared to the previous close of Rs. 27.05. The total number of shares traded during the day was 227840 in over 548 trades.

The stock hit an intraday high of Rs. 27.9 and intraday low of 26.6. The net turnover during the day was Rs. 6284638.

Source : Equity Bulls

Keywords